Gilead Sciences - 34 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. The latest closing stock price for Gilead Sciences as of February 11, 2026 is 155.80.

The all-time high Gilead Sciences stock closing price was 155.80 on February 11, 2026.
The Gilead Sciences 52-week high stock price is 157.29, which is 1% above the current share price.
The Gilead Sciences 52-week low stock price is 93.37, which is 40.1% below the current share price.
The average Gilead Sciences stock price for the last 52 weeks is 115.82.

Gilead Sciences Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	133.9732	121.6000	155.8000	118.3000	155.8000	26.93%
2025	109.7059	89.3812	127.2300	86.7157	122.7400	36.59%
2024	73.8633	77.7970	94.4437	59.8896	89.8579	18.68%
2023	72.5246	76.8384	79.2590	67.8170	75.7128	-1.99%
2022	58.9758	62.4611	79.8475	49.8450	77.2523	23.63%
2021	56.8947	49.6104	63.3733	49.5196	62.4869	29.95%
2020	55.4456	51.7350	67.2422	46.7547	48.0835	-6.70%
2019	50.9852	48.4517	54.0105	47.7098	51.5367	7.88%
2018	55.3351	54.8538	65.7357	46.2368	47.7720	-9.92%
2017	52.7141	53.3436	62.4505	46.4767	53.0327	2.96%
2016	59.2735	68.9046	72.2601	51.2871	51.5094	-27.59%
2015	74.2680	65.9389	85.2131	65.9389	71.1402	8.63%
2014	62.2349	52.2522	79.3545	45.4923	65.4873	25.51%
2013	38.9481	26.0740	52.2453	26.0358	52.1758	104.49%
2012	19.6340	14.5411	26.5187	14.5411	25.5147	79.45%
2011	13.8700	12.7070	15.0101	12.2763	14.2181	12.94%
2010	13.6417	15.0414	17.1777	11.0570	12.5889	-16.25%
2009	16.0193	18.1261	18.3414	14.3952	15.0309	-15.39%
2008	17.0855	15.7500	19.8352	13.0162	17.7648	11.15%
2007	13.7491	10.9684	16.5837	10.8954	15.9828	41.72%
2006	10.7530	9.5007	12.1147	9.3357	11.2776	23.51%
2005	7.3428	6.0322	9.6623	5.3913	9.1308	50.24%
2004	5.5882	5.0387	6.7808	4.4950	6.0773	20.07%
2003	4.4718	3.0300	6.0782	2.8051	5.0613	71.41%
2002	2.9577	2.6674	3.4486	2.3057	2.9527	3.47%
2001	2.1773	1.6093	3.1355	1.1737	2.8537	58.48%
2000	1.6358	1.2226	2.5222	0.9431	1.8007	53.24%
1999	1.1589	0.8630	2.0056	0.7762	1.1751	31.81%
1998	0.6924	0.8277	0.9390	0.3962	0.8915	7.36%
1997	0.6807	0.5319	1.0014	0.4695	0.8304	52.98%
1996	0.6169	0.7083	0.9091	0.3745	0.5428	-21.88%
1995	0.4002	0.2035	0.7002	0.2035	0.6948	236.79%
1994	0.2184	0.2605	0.3040	0.1520	0.2063	-20.81%
1993	0.3211	0.3962	0.4152	0.2334	0.2605	-37.66%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$182.665B	$29.443B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$299.946B	23.88
Amgen (AMGN)	United States	$196.357B	16.69
Bristol Myers Squibb (BMY)	United States	$123.896B	9.90
GSK (GSK)	United Kingdom	$119.899B	13.01
Vertex Pharmaceuticals (VRTX)	United States	$117.594B	30.27
Regeneron Pharmaceuticals (REGN)	United States	$79.341B	20.92
CSL (CSLLY)	Australia	$57.238B	0.00
Argenex SE (ARGX)	Netherlands	$51.559B	63.70
Alnylam Pharmaceuticals (ALNY)	United States	$42.670B	1404.26
Insmed (INSM)	United States	$31.682B	0.00
Biogen (BIIB)	United States	$27.736B	12.36
Royalty Pharma (RPRX)	United States	$25.520B	9.78
BioNTech SE (BNTX)	Germany	$24.529B	0.00
Exact Sciences (EXAS)	United States	$19.720B	543.95
Genmab (GMAB)	Denmark	$19.657B	14.78
Incyte (INCY)	United States	$19.642B	17.28
Roivant Sciences (ROIV)	United Kingdom	$19.022B	0.00
Revolution Medicines (RVMD)	United States	$18.555B	0.00
Illumina (ILMN)	United States	$18.232B	24.60
Moderna (MRNA)	United States	$16.409B	0.00
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$14.594B	0.00
Ascendis Pharma (ASND)	Denmark	$13.895B	0.00
Guardant Health (GH)	United States	$13.238B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$13.193B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
Exelixis (EXEL)	United States	$11.523B	15.74
BioMarin Pharmaceutical (BMRN)	United States	$11.462B	20.79
Avidity Biosciences (RNA)	United States	$11.279B	0.00
QIAGEN (QGEN)	Netherlands	$10.787B	20.66
Bio-Techne Corp (TECH)	United States	$10.138B	36.82
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.065B	39.25
Halozyme Therapeutics (HALO)	United States	$9.434B	15.08
Abivax SA (ABVX)	France	$9.349B	0.00
Axsome Therapeutics (AXSM)	United States	$9.291B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$8.811B	41.12
Praxis Precision Medicines (PRAX)	United States	$8.075B	0.00
Repligen (RGEN)	United States	$8.053B	86.18
Bio-Rad Laboratories (BIO.B)	United States	$7.959B	28.62
Cytokinetics (CYTK)	United States	$7.929B	0.00
Krystal Biotech (KRYS)	United States	$7.850B	40.58
Nuvalent (NUVL)	United States	$7.422B	0.00
Vaxcyte (PCVX)	United States	$7.197B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.865B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Belite Bio (BLTE)	United States	$6.637B	0.00
ImmunityBio (IBRX)	United States	$6.461B	0.00
PTC Therapeutics (PTCT)	United States	$5.792B	7.87
Alkermes (ALKS)	Ireland	$5.733B	16.85
Kymera Therapeutics (KYMR)	United States	$5.719B	0.00
Immunovant (IMVT)	United States	$5.430B	0.00
Cogent Biosciences (COGT)	United States	$5.378B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.244B	135.29
Mirum Pharmaceuticals (MIRM)	United States	$5.186B	0.00
Scholar Rock Holding (SRRK)	United States	$4.860B	0.00
Celcuity (CELC)	United States	$4.820B	0.00
Structure Therapeutics (GPCR)	United States	$4.766B	0.00
CRISPR Therapeutics AG (CRSP)	Switzerland	$4.654B	0.00
TG Therapeutics (TGTX)	United States	$4.626B	10.48
Zealand Pharma (ZLDPF)	Denmark	$4.551B	4.61
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.489B	357.50
Apogee Therapeutics (APGE)	United States	$4.475B	0.00
CG Oncology (CGON)	United States	$4.283B	0.00
GRAIL (GRAL)	United States	$4.042B	0.00
Arcellx (ACLX)	United States	$3.888B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.875B	27.59
ACADIA Pharmaceuticals (ACAD)	United States	$3.840B	32.43
Erasca (ERAS)	United States	$3.700B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.681B	90.35
Anbio Biotechnology (NNNN)	Germany	$3.583B	0.00
Liquidia (LQDA)	United States	$3.527B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.440B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.389B	99.36
Legend Biotech (LEGN)	United States	$3.308B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.294B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.293B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.282B	0.00
Viking Therapeutics (VKTX)	United States	$3.250B	0.00
Twist Bioscience (TWST)	United States	$3.008B	0.00
IDEAYA Biosciences (IDYA)	United States	$2.915B	0.00
Denali Therapeutics (DNLI)	United States	$2.907B	0.00
Viridian Therapeutics (VRDN)	United States	$2.869B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.857B	72.84
Disc Medicine (IRON)	United States	$2.822B	0.00
Vera Therapeutics (VERA)	United States	$2.816B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.798B	0.00
Alumis (ALMS)	United States	$2.776B	0.00
Immunome (IMNM)	United States	$2.751B	0.00
Beam Therapeutics (BEAM)	United States	$2.735B	0.00
Travere Therapeutics (TVTX)	United States	$2.713B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.610B	0.00
Spyre Therapeutics (SYRE)	United States	$2.604B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.459B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.453B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.440B	6.62
Adaptive Biotechnologies (ADPT)	United States	$2.388B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.335B	0.00
Maze Therapeutics (MAZE)	United States	$2.328B	0.00
Mesoblast (MESO)	Australia	$2.321B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.272B	0.00
Arcus Biosciences (RCUS)	United States	$2.244B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.240B	0.00
Dianthus Therapeutics (DNTH)	United States	$2.197B	0.00
Zai Lab (ZLAB)	China	$2.189B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.185B	11.93
Recursion Pharmaceuticals (RXRX)	United States	$2.001B	0.00
Nuvation Bio (NUVB)	United States	$1.958B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.921B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.853B	0.00
Stoke Therapeutics (STOK)	United States	$1.853B	48.42
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
Vericel (VCEL)	United States	$1.800B	148.29
ANI Pharmaceuticals (ANIP)	United States	$1.796B	13.92
MannKind (MNKD)	United States	$1.790B	58.30
Tango Therapeutics (TNGX)	United States	$1.709B	0.00
Zymeworks (ZYME)	United States	$1.701B	0.00
Sionna Therapeutics (SION)	United States	$1.697B	0.00
MBX Biosciences (MBX)	United States	$1.692B	0.00
Nurix Therapeutics (NRIX)	United States	$1.692B	0.00
Tyra Biosciences (TYRA)	United States	$1.676B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.658B	0.00
Precigen (PGEN)	United States	$1.649B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.640B	0.00
Celldex Therapeutics (CLDX)	United States	$1.637B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.605B	0.00
Rapt Therapeutics (RAPT)	United States	$1.600B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.582B	0.00
Alvotech (ALVO)	Luxembourg	$1.568B	22.61
UniQure (QURE)	Netherlands	$1.539B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.513B	0.00
Upstream Bio (UPB)	United States	$1.503B	0.00
NeoGenomics (NEO)	United States	$1.488B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Trevi Therapeutics (TRVI)	United States	$1.443B	0.00
Novavax (NVAX)	United States	$1.422B	3.62
AtaiBeckley Inc (ATAI)	Netherlands	$1.398B	0.00
AnaptysBio (ANAB)	United States	$1.391B	0.00
Intellia Therapeutics (NTLA)	United States	$1.380B	0.00
Rapport Therapeutics (RAPP)	United States	$1.346B	0.00
Biohaven (BHVN)	United States	$1.291B	0.00
Nanobiotix S.A - (NBTX)	France	$1.279B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.274B	61.16
Fortrea Holdings (FTRE)	United States	$1.263B	26.80
Kodiak Sciences (KOD)	United States	$1.237B	0.00
Inhibrx Biosciences (INBX)	United States	$1.211B	0.00
Immatics (IMTX)	Germany	$1.207B	0.00
Septerna (SEPN)	United States	$1.195B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.193B	0.00
Compass Therapeutics (CMPX)	United States	$1.174B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.173B	0.00
NovoCure (NVCR)	Jersey	$1.172B	0.00
Zenas BioPharma (ZBIO)	United States	$1.153B	0.00
EyePoint (EYPT)	United States	$1.136B	0.00
Pharming Group (PHAR)	Netherlands	$1.136B	0.00
Certara (CERT)	United States	$1.115B	20.59
Vir Biotechnology (VIR)	United States	$1.045B	0.00
Geron (GERN)	United States	$1.034B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.032B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.028B	0.00
Sana Biotechnology (SANA)	United States	$1.028B	0.00
Urogen Pharma (URGN)	United States	$1.014B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.003B	0.00
Ventyx Biosciences (VTYX)	United States	$1.002B	0.00
Palvella Therapeutics (PVLA)	United States	$0.959B	0.00
DBV Technologies S.A (DBVT)	France	$0.956B	0.00
AbCellera Biologics (ABCL)	Canada	$0.946B	0.00
Castle Biosciences (CSTL)	United States	$0.945B	129.48
CytomX Therapeutics (CTMX)	United States	$0.937B	13.82
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Inventiva S.A (IVA)	France	$0.918B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.916B	0.00
Evommune (EVMN)	United States	$0.915B	0.00
Pacira BioSciences (PCRX)	United States	$0.914B	10.46
ArriVent BioPharma (AVBP)	United States	$0.870B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.867B	0.00
Arvinas (ARVN)	United States	$0.863B	0.00
Bicara Therapeutics (BCAX)	United States	$0.820B	0.00
MapLight Therapeutics (MPLT)	United States	$0.812B	0.00
Arbutus Biopharma (ABUS)	United States	$0.800B	0.00
GH Research (GHRS)	Ireland	$0.798B	0.00
YD Bio (YDES)		$0.790B	0.00
Janux Therapeutics (JANX)	United States	$0.790B	0.00
Gyre Therapeutics (GYRE)	United States	$0.768B	99.62
MiMedx (MDXG)	United States	$0.766B	13.60
Bright Minds Biosciences (DRUG)	United States	$0.729B	0.00
BioAge Labs (BIOA)	United States	$0.724B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.720B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
Jade Biosciences (JBIO)	United States	$0.716B	0.00
Kura Oncology (KURA)	United States	$0.682B	0.00
Annexon (ANNX)	United States	$0.671B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Replimune (REPL)	United States	$0.644B	0.00
EnGene Holdings (ENGN)	Canada	$0.638B	0.00
Prime Medicine (PRME)	United States	$0.617B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.613B	0.00
CorMedix Inc (CRMD)	United States	$0.606B	5.61
MeiraGTx Holdings (MGTX)	United States	$0.605B	0.00
Design Therapeutics (DSGN)	United States	$0.583B	0.00
Emergent Biosolutions (EBS)	United States	$0.580B	5.58
Fulcrum Therapeutics (FULC)	United States	$0.560B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.559B	0.00
Cytek Biosciences (CTKB)	United States	$0.551B	0.00
Solid Biosciences (SLDB)	United States	$0.540B	0.00
Gossamer Bio (GOSS)	United States	$0.539B	0.00
SELLAS Life Sciences (SLS)	United States	$0.536B	0.00
Keros Therapeutics (KROS)	United States	$0.522B	11.14
Alto Neuroscience (ANRO)	United States	$0.517B	0.00
Neumora Therapeutics (NMRA)	United States	$0.500B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.483B	0.00
Prothena (PRTA)	Ireland	$0.482B	0.00
Kamada (KMDA)	Israel	$0.481B	23.22
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Myriad Genetics (MYGN)	United States	$0.474B	0.00
Contineum Therapeutics (CTNM)	United States	$0.460B	0.00
REGENXBIO (RGNX)	United States	$0.448B	0.00
Ocugen (OCGN)	United States	$0.443B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.439B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.435B	0.00
LENZ Therapeutics (LENZ)	United States	$0.427B	0.00
PureTech Health (PRTC)	United States	$0.422B	0.00
Verastem (VSTM)	United States	$0.419B	0.00
Zura Bio (ZURA)	United States	$0.419B	0.00
Entrada Therapeutics (TRDA)	United States	$0.414B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.410B	0.00
Prima BioMed (IMMP)	Australia	$0.410B	0.00
Niagen Bioscience (NAGE)	United States	$0.409B	32.00
Eton Pharmaceuticals (ETON)	United States	$0.408B	0.00
Benitec Biopharma (BNTC)	United States	$0.401B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.399B	0.00
Absci (ABSI)	United States	$0.397B	0.00
NovaBridge Biosciences (NBP)	United States	$0.394B	0.00
Tectonic Therapeutic (TECX)	United States	$0.394B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.391B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.388B	0.00
Monopar Therapeutics (MNPR)	United States	$0.381B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.381B	0.00
Invivyd (IVVD)	United States	$0.380B	0.00
Allogene Therapeutics (ALLO)	United States	$0.380B	0.00
PepGen (PEPG)	United States	$0.379B	0.00
Climb Bio (CLYM)	United States	$0.375B	0.00
GENFIT S.A (GNFTY)	France	$0.371B	0.00
Forte Biosciences (FBRX)	United States	$0.369B	0.00
Anavex Life Sciences (AVXL)	United States	$0.367B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.361B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.359B	0.00
Aura Biosciences (AURA)	United States	$0.358B	0.00
Immix Biopharma (IMMX)	United States	$0.356B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.351B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.344B	0.00
Puma Biotechnology (PBYI)	United States	$0.333B	8.93
Atea Pharmaceuticals (AVIR)	United States	$0.325B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.324B	0.00
Immuneering (IMRX)	United States	$0.324B	0.00
Candel Therapeutics (CADL)	United States	$0.316B	0.00
Amarin (AMRN)	Ireland	$0.312B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.308B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.308B	0.00
AC Immune (ACIU)	Switzerland	$0.307B	0.00
Rezolute (RZLT)	United States	$0.285B	0.00
XOMA Royalty (XOMA)	United States	$0.283B	0.00
Abeona Therapeutics (ABEO)	United States	$0.277B	4.53
Lifecore Biomedical (LFCR)	United States	$0.277B	0.00
Aardvark Therapeutics (AARD)	United States	$0.275B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.268B	0.00
Adherex Technologies (FENC)	United States	$0.267B	0.00
Neurogene (NGNE)	United States	$0.263B	0.00
Palisade Bio (PALI)	United States	$0.258B	0.00
Shattuck Labs (STTK)	United States	$0.257B	0.00
Coherus Oncology (CHRS)	United States	$0.255B	0.00
Cabaletta Bio (CABA)	United States	$0.250B	0.00
Opus Genetics (IRD)	United States	$0.241B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.235B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Nuvectis Pharma (NVCT)	United States	$0.224B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.215B	0.00
Alector (ALEC)	United States	$0.213B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.213B	0.00
Voyager Therapeutics (VYGR)	United States	$0.206B	0.00
SAB Biotherapeutics (SABS)	United States	$0.199B	0.00
Humacyte (HUMA)	United States	$0.197B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.191B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.187B	0.00
Sagimet Biosciences (SGMT)	United States	$0.183B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.179B	0.00
C4 Therapeutics (CCCC)	United States	$0.178B	0.00
Tharimmune (THAR)	United States	$0.176B	0.00
Editas Medicine (EDIT)	United States	$0.174B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.173B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.168B	0.00
Satellos Bioscience (MSLE)	Canada	$0.168B	0.00
Innate Pharma S.A (IPHA)	France	$0.166B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.163B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.157B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.156B	0.00
Alps Group (ALPS)	United States	$0.156B	2.84
Elicio Therapeutics (ELTX)	United States	$0.152B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.150B	0.00
Anika Therapeutics (ANIK)	United States	$0.149B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.148B	0.00
Caribou Biosciences (CRBU)	United States	$0.147B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Vor Biopharma (VOR)		$0.145B	0.00
Nkarta (NKTX)	United States	$0.142B	0.00
Adagene (ADAG)	China	$0.140B	0.00
VTv Therapeutics (VTVT)	United States	$0.138B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.138B	0.00
Sutro Biopharma (STRO)	United States	$0.133B	0.00
Spero Therapeutics (SPRO)	United States	$0.133B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.132B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.132B	0.00
Crescent Biopharma (CBIO)	United States	$0.131B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.131B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.130B	6.33
Seres Therapeutics (MCRB)	United States	$0.129B	0.00
BGM Group (BGM)	China	$0.129B	0.00
Fate Therapeutics (FATE)	United States	$0.126B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.125B	0.00
Jyong Biotech (MENS)	Taiwan	$0.123B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.118B	0.00
Ovid Therapeutics (OVID)	United States	$0.117B	0.00
Alpha Cognition (ACOG)	Canada	$0.117B	0.00
Fortress Biotech (FBIO)	United States	$0.116B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Codexis (CDXS)	United States	$0.113B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.113B	0.00
Alpha Teknova (TKNO)	United States	$0.112B	0.00
Turn Therapeutics (TTRX)	United States	$0.110B	0.00
BioStem Technologies (BSEM)		$0.106B	7.39
Agenus (AGEN)	United States	$0.104B	0.00
Cardiff Oncology (CRDF)	United States	$0.104B	0.00
Coya Therapeutics (COYA)	United States	$0.104B	0.00
Cognition Therapeutics (CGTX)	United States	$0.101B	0.00
Citius Oncology (CTOR)	United States	$0.100B	0.00
Actuate Therapeutics (ACTU)	United States	$0.099B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.099B	0.00
Seer (SEER)	United States	$0.099B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Immunic (IMUX)	United States	$0.096B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.095B	0.00
Biomea Fusion (BMEA)	United States	$0.095B	0.00
Equillium (EQ)	United States	$0.093B	0.00
Genelux (GNLX)	United States	$0.092B	0.00
Spruce Biosciences (SPRB)	United States	$0.090B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.089B	0.00
EXoZymes (EXOZ)	United States	$0.087B	0.00
ATyr Pharma (ATYR)	United States	$0.086B	0.00
Precision BioSciences (DTIL)	United States	$0.086B	0.00
MaxCyte (MXCT)	United States	$0.082B	0.00
ImageneBio (IMA)	United States	$0.082B	0.00
BioHarvest Sciences (BHST)	Canada	$0.081B	0.00
MediciNova (MNOV)	United States	$0.080B	0.00
Tenax Therapeutics (TENX)	United States	$0.080B	0.00
TuHURA Biosciences (HURA)	United States	$0.079B	0.00
OKYO Pharma (OKYO)		$0.079B	0.00
Scilex Holding (SCLX)	United States	$0.076B	0.00
IBio (IBIO)	United States	$0.074B	0.00
XBiotech (XBIT)	United States	$0.074B	0.00
Pliant Therapeutics (PLRX)	United States	$0.071B	0.00
Adicet Bio (ACET)	United States	$0.068B	0.00
Entera Bio (ENTX)	Israel	$0.066B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.065B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.065B	0.00
Annovis Bio (ANVS)	United States	$0.064B	0.00
BeyondSpring (BYSI)	United States	$0.060B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.060B	0.00
Grace Therapeutics (GRCE)	United States	$0.057B	0.00
InflaRx (IFRX)	Germany	$0.057B	0.00
TScan Therapeutics (TCRX)	United States	$0.057B	0.00
MiNK Therapeutics (INKT)	United States	$0.053B	0.00
Instil Bio (TIL)	United States	$0.052B	0.00
Estrella Immunopharma (ESLA)	United States	$0.052B	0.00
Cingulate (CING)	United States	$0.051B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.051B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.050B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.048B	0.00
Clene (CLNN)	United States	$0.048B	0.00
Q32 Bio (QTTB)	United States	$0.047B	0.00
CervoMed (CRVO)	United States	$0.047B	0.00
Kezar Life Sciences (KZR)	United States	$0.046B	0.00
Aligos Therapeutics (ALGS)	United States	$0.044B	0.00
ABVC BioPharma (ABVC)	United States	$0.043B	0.00
NextCure (NXTC)	United States	$0.043B	0.00
INmune Bio (INMB)	United States	$0.043B	0.00
Elutia (ELUT)	United States	$0.041B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Pluri (PLUR)	Israel	$0.038B	0.00
Jasper Therapeutics (JSPR)	United States	$0.037B	0.00
Celularity (CELU)	United States	$0.037B	0.00
Xilio Therapeutics (XLO)	United States	$0.037B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.036B	0.00
RenovoRx (RNXT)	United States	$0.036B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
PDS Biotechnology (PDSB)	United States	$0.035B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.035B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.035B	2.22
Galecto (GLTO)	Denmark	$0.034B	0.00
OnKure Therapeutics (OKUR)	United States	$0.034B	0.00
TELA Bio (TELA)	United States	$0.033B	0.00
Lantern Pharma (LTRN)	United States	$0.033B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.031B	0.00
Oncobiologics (OTLK)	United States	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Promis Neurosciences (PMN)	Canada	$0.031B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.031B	0.00
Hyperion DeFi (HYPD)	United States	$0.030B	0.00
AN2 Therapeutics (ANTX)	United States	$0.030B	0.00
Dyadic (DYAI)	United States	$0.030B	0.00
Rein Therapeutics (RNTX)	United States	$0.030B	0.00
Femasys (FEMY)	United States	$0.030B	0.00
Passage Bio (PASG)	United States	$0.030B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Exicure (XCUR)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Cue Biopharma (CUE)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.026B	0.00
Medicus Pharma (MDCX)	United States	$0.026B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Boundless Bio (BOLD)	United States	$0.025B	0.00
Aytu BioPharma (AYTU)	United States	$0.025B	0.00
Dare Bioscience (DARE)	United States	$0.024B	0.00
Senti Biosciences (SNTI)	United States	$0.023B	0.00
Skye Bioscience (SKYE)	United States	$0.023B	0.00
Intensity Therapeutics (INTS)	United States	$0.022B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
Apollomics (APLM)	United States	$0.021B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.020B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.020B	0.00
LeonaBio (LONA)	United States	$0.019B	0.00
IN8bio (INAB)	United States	$0.019B	0.00
FibroBiologics (FBLG)	United States	$0.018B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.018B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.017B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.017B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Quantum Biopharma (QNTM)	Canada	$0.015B	0.00
Allarity Therapeutics (ALLR)	United States	$0.015B	0.00
Hoth Therapeutics (HOTH)	United States	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.014B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Curis (CRIS)	United States	$0.014B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.014B	0.00
BioCardia (BCDA)	United States	$0.013B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
BioAtla (BCAB)	United States	$0.013B	0.00
Bionano Genomics (BNGO)	United States	$0.012B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
CalciMedica (CALC)	United States	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Revelation Biosciences (REVB)	United States	$0.011B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.010B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
Novogen (KZIA)	Australia	$0.009B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.009B	0.00
Beyond Air (XAIR)	United States	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.008B	0.00
Mainz Biomed (MYNZ)	Germany	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
Gelteq (GELS)	Australia	$0.008B	0.00
Alzamend Neuro (ALZN)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
GENPREX (GNPX)	United States	$0.007B	0.00
Mustang Bio (MBIO)	United States	$0.006B	0.00
IMMURON (IMRN)	Australia	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Biorestorative Therapies (BRTX)	United States	$0.006B	0.00
GT Biopharma (GTBP)	United States	$0.005B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Dermata Therapeutics (DRMA)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
GeoVax Labs (GOVX)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Abpro Holdings (ABP)	United States	$0.005B	0.00
BioAffinity Technologies (BIAF)	United States	$0.005B	0.00
Aprea Therapeutics (APRE)	United States	$0.004B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
HCW Biologics (HCWB)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Avalon GloboCare (ALBT)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
Quince Therapeutics (QNCX)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00